(Health-NewsWire.Net, November 03, 2016 ) DelveInsight Drug Report, "Efient- Drug Insights, 2016" highlights the Efient marketed details, pipeline status and the Global API Manufacturers along with the location. The DelveInsight's report covers the Global Market Assessment of the Efient covering the total sales estimation and also provides the Efient sales performance during the historical period and forecast period to 2018. DelveInsight's Report also covers the detailed clinical assessment of Efient, patents information and exclusivity data, route of synthesis, competitive landscape, and generic players. In addition to this, DelveInsight's Report provides the SWOT analysis for the Efient.
1. DelveInsight Report Introduction 2. Efient Overview 2.1 Market Competition 2.3 Competitors in Development 3 Global Sales Assessment 3.1 Historical Sales of Somavert 3.2 Forecasted Sales of Somavert 4 Product Description 4.1 Mechanism of Action 4.2 Pharmacodynamic Properties 4.3 Pharmacokinetic Properties 5 Marketed Details 5.1 United States 5.2 Europe 6 Patent Information 6.1 Patent Numbers and Expiry Details 6.2 Patent and Exclusivity Expiry Assessment United States (US) 6.3 Patent Details 7 Route of Synthesis 8 Global API Manufacturers Assessment 8.1 The United States Drug Master File (US DMF) 8.2 The Europe Drug Master File (EUDMF)/Active Substance Master File (ASMF) 8.3 The Active Pharmaceutical Ingredient (API) Manufacturers in China 8.4 The Active Pharmaceutical Ingredient (API) Manufacturers in India 9 Generic Players 10 The Pipeline Coverage 11 Clinical Trials Information 11.1 Clinical Trials by Zone 12 Company Profile 12.1 Company Summary 12.2 Company Financials 13 SWOT Analysis 14 References 15 Appendix 16 Methodology 17 Consulting Services 18 About DelveInsight 19 Contact Us 20 Disclaimer Make an enquiry: http://www.reportsweb.com/inquiry&RW000182660/buying